about
Celiac Disease-Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell DynamicsUSF1 deficiency activates brown adipose tissue and improves cardiometabolic healthSiglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be used in PET imaging of inflammation and cancer.Assessment of blood flow with (68)Ga-DOTA PET in experimental inflammation: a validation study using (15)O-water.Preliminary evaluation of novel 68Ga-DOTAVAP-PEG-P2 peptide targeting vascular adhesion protein-1.Biodistribution and radiation dosimetry of [(11)C]choline: a comparison between rat and human data.Persistence of parvovirus B19 in synovial fluid and bone marrow.Pretargeted PET Imaging of trans-Cyclooctene-Modified Porous Silicon Nanoparticles.Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG.(68)Ga-DOTA-Siglec-9 PET/CT imaging of peri-implant tissue responses and staphylococcal infectionsSomatostatin receptor subtype 2 in high-grade gliomas: PET/CT with (68)Ga-DOTA-peptides, correlation to prognostic markers, and implications for targeted radiotherapyUptake of 68gallium in atherosclerotic plaques in LDLR-/-ApoB100/100 mice.[18F]FDG Accumulation in Early Coronary Atherosclerotic Lesions in Pigs.Absorption, distribution and excretion of intravenously injected (68)Ge/ (68)Ga generator eluate in healthy rats, and estimation of human radiation dosimetryA comparative 18F-FDG PET/CT imaging of experimental Staphylococcus aureus osteomyelitis and Staphylococcus epidermidis foreign-body-associated infection in the rabbit tibia.68Ga-DOTA-Siglec-9--a new imaging tool to detect synovitisA Novel Positron Emission Tomography (PET) Approach to Monitor Cardiac Metabolic Pathway Remodeling in Response to Sunitinib Malate.Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer ¹⁸F-fluoromethylcholineNuclear imaging of inflammation: homing-associated molecules as targets.Feasibility of (68)Ga-labeled Siglec-9 peptide for the imaging of acute lung inflammation: a pilot study in a porcine model of acute respiratory distress syndrome.Characterization of hepatic tumors using [11C]metomidate through positron emission tomography: comparison with [11C]acetateLeukocyte trafficking-associated vascular adhesion protein 1 is expressed and functionally active in atherosclerotic plaques.Accuracy of echocardiographic area-length method in chronic myocardial infarction: comparison with cardiac CT in pigs.Gallium-labelled peptides for imaging of inflammation.68Ga-labeled oligonucleotides for in vivo imaging with PET.In vivo imaging of Lyme arthritis in mice by [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography.Feasibility of experimental BT4C glioma models for somatostatin receptor 2-targeted therapies.Matrix metalloproteinase 9 targeting peptides: syntheses, 68Ga-labeling, and preliminary evaluation in a rat melanoma xenograft model.PET imaging of inflammation and adenocarcinoma xenografts using vascular adhesion protein 1 targeting peptide 68Ga-DOTAVAP-P1: comparison with 18F-FDG.Non-specific binding of [18F]FDG to calcifications in atherosclerotic plaques: experimental study of mouse and human arteries.68Ga-chloride PET reveals human pancreatic adenocarcinoma xenografts in rats--comparison with FDG.68Ga-DOTA-RGD peptide: biodistribution and binding into atherosclerotic plaques in mice.Mini-PEG spacering of VAP-1-targeting 68Ga-DOTAVAP-P1 peptide improves PET imaging of inflammation.Biodistribution of 68Ga-labelled phosphodiester, phosphorothioate, and 2'-O-methyl phosphodiester oligonucleotides in normal rats.Age-, sex- and glucose-dependent correlation of plasma soluble vascular adhesion protein-1 concentration with cardiovascular risk factors and subclinical atherosclerosis.18F-FDG positron emission tomography/computed tomography in infective endocarditis.(18)F-Labeling of Mannan for Inflammation Research with Positron Emission Tomography.Imaging of αvβ3 integrin expression in experimental myocardial ischemia with [68Ga]NODAGA-RGD positron emission tomography.[(18)F]-fluorodeoxyglucose positron emission tomography and computed tomography in response evaluation of oncolytic adenovirus treatments of patients with advanced cancer.Identification of alpha6beta1 integrin positive cells in synovial lining layer as type B synoviocytes.
P50
Q27316086-F6A84FF2-C8C8-4D3F-AA6A-1778D7FDC721Q28272648-48971BDC-CAB8-40CC-B810-9DB61E697DE6Q30557434-4CEE2969-75C8-42FD-8117-8955C8F15D08Q30854806-C3AF4083-F608-4C07-B682-74D9282FEE41Q33511334-63D6F1BA-98F1-4CEB-AEE5-7177F0B9657FQ33523536-86528041-7A9B-4033-8F59-31207777E697Q33578180-8D182A86-E728-4231-BEFA-536AA610CC54Q33817609-254693E3-DB86-4939-8949-A160717E3A48Q34325054-10012D9E-1FF1-4F4B-95BD-3596968A00F5Q34699288-8AFE2071-37C5-41AB-926A-2283937484F5Q35572487-B9CD0240-4C4C-49AD-BC05-C938DD71ADC8Q35651449-8932C3E6-C552-4C22-9CDA-592DB35E6535Q35676899-B4F2A763-33F6-4B70-BD4A-C5C728A83618Q35858931-84C43112-EC50-43E0-94FB-AC3FB53F5A22Q36150256-9FD01DDC-DA39-4282-9E33-68EB0DFC5C05Q36246891-6897DA3D-9630-4746-AD27-ED8D2D67C1EEQ36262416-0128B35A-4D2C-45A7-90C5-C9BCC2A1EC74Q36553346-031ABF4F-F81D-4814-978A-03E241E75DFAQ36568208-234CAE7B-55B0-4C30-8430-673AEAA542CAQ36568320-E199FF71-D4AF-4445-8908-DC000EB8EC18Q36687495-88E3B0DF-577C-4241-8EB3-7B0845943402Q37330522-84B7FD51-A10C-47CD-9431-4D38CB10B240Q37576221-4E1904C1-0783-457E-A1AC-20210317B1F4Q37990395-EF65AC2A-444D-42A8-945B-9912E95AD85CQ38344813-380B96E9-2DBA-4446-89E8-75F0B68BDAE9Q38709331-DBA2DC84-1101-40CC-A4DA-36E3DFBF77F0Q38981899-A10B7720-5D34-4D00-9B47-ACFF95FE33FAQ39663213-19230F2D-A20E-42AE-9A96-BAE4C37AF17AQ39696743-617D28C9-BB4D-43D9-AAF0-2B7C061EA9CCQ39762487-1D53A919-9519-4627-88D1-A9BED87CAAA0Q39792434-101B8529-C586-4AE1-8606-5EB09A4325E1Q39894168-0A54A33F-D2CA-4E06-83E7-9C021AE6A4E2Q40157730-57A80824-C106-4049-9694-8C3E2CB94A6DQ40415937-E4243560-54C6-4815-92FE-C5C85AF8EE6AQ40763256-730F424F-6AAF-489D-BF07-B1E99095DF67Q40873445-ABC2B538-2DEF-443E-A876-1ABBF2CC7B1EQ41064055-20C5ADA4-0DC4-4582-B2A7-E003F7E3423BQ41091918-E53804CF-76A8-484D-8EE4-B0716553B647Q42264406-EA20A1D5-5B80-42FA-8462-53E1CC7B0B88Q42502636-B8986647-A343-472C-97D7-CC83C4085CFD
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anne Roivainen
@ast
Anne Roivainen
@en
Anne Roivainen
@es
Anne Roivainen
@nl
type
label
Anne Roivainen
@ast
Anne Roivainen
@en
Anne Roivainen
@es
Anne Roivainen
@nl
prefLabel
Anne Roivainen
@ast
Anne Roivainen
@en
Anne Roivainen
@es
Anne Roivainen
@nl
P106
P1153
6603698387
P21
P31
P496
0000-0002-4006-7977